BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17690255)

  • 41. The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection.
    Mariano FS; Gutierrez FR; Pavanelli WR; Milanezi CM; Cavassani KA; Moreira AP; Ferreira BR; Cunha FQ; Cardoso CR; Silva JS
    Microbes Infect; 2008 Jun; 10(7):825-33. PubMed ID: 18538611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conversion of alloantigen-specific CD8+ T cell anergy to CD8+ T cell priming through in vivo ligation of glucocorticoid-induced TNF receptor.
    Kim J; Choi WS; Kang H; Kim HJ; Suh JH; Sakaguchi S; Kwon B
    J Immunol; 2006 May; 176(9):5223-31. PubMed ID: 16621987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
    Mitsui J; Nishikawa H; Muraoka D; Wang L; Noguchi T; Sato E; Kondo S; Allison JP; Sakaguchi S; Old LJ; Kato T; Shiku H
    Clin Cancer Res; 2010 May; 16(10):2781-91. PubMed ID: 20460483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis.
    Cuzzocrea S; Ayroldi E; Di Paola R; Agostini M; Mazzon E; Bruscoli S; Genovese T; Ronchetti S; Caputi AP; Riccardi C
    FASEB J; 2005 Aug; 19(10):1253-65. PubMed ID: 16051692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation.
    Quezada SA; Bennett K; Blazar BR; Rudensky AY; Sakaguchi S; Noelle RJ
    J Immunol; 2005 Jul; 175(2):771-9. PubMed ID: 16002673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucocorticoid-induced TNF receptor functions as a costimulatory receptor that promotes survival in early phases of T cell activation.
    Esparza EM; Arch RH
    J Immunol; 2005 Jun; 174(12):7869-74. PubMed ID: 15944292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis.
    Li Z; Mahesh SP; Kim BJ; Buggage RR; Nussenblatt RB
    J Autoimmun; 2003 Aug; 21(1):83-92. PubMed ID: 12892739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of humoral and cellular immunity with an anti-glucocorticoid-induced tumour necrosis factor receptor monoclonal antibody.
    Ponte JF; Ponath P; Gulati R; Slavonic M; Paglia M; O'Shea A; Tone M; Waldmann H; Vaickus L; Rosenzweig M
    Immunology; 2010 Jun; 130(2):231-42. PubMed ID: 20201988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of murine gammadelta lymphocyte expansion and effector function by regulatory alphabeta T cells is cell-contact-dependent and sensitive to GITR modulation.
    Gonçalves-Sousa N; Ribot JC; deBarros A; Correia DV; Caramalho I; Silva-Santos B
    Eur J Immunol; 2010 Jan; 40(1):61-70. PubMed ID: 19877017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology.
    Suvas S; Kim B; Sarangi PP; Tone M; Waldmann H; Rouse BT
    J Virol; 2005 Sep; 79(18):11935-42. PubMed ID: 16140769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of CTLA-4 and GITR for cancer immunotherapy.
    Avogadri F; Yuan J; Yang A; Schaer D; Wolchok JD
    Curr Top Microbiol Immunol; 2011; 344():211-44. PubMed ID: 20563707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?
    Shevach EM; Stephens GL
    Nat Rev Immunol; 2006 Aug; 6(8):613-8. PubMed ID: 16868552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Mittler RS; Yagita H; Ueno H
    J Immunol; 2005 Oct; 175(8):4897-903. PubMed ID: 16210591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants.
    Cobbold SP; Castejon R; Adams E; Zelenika D; Graca L; Humm S; Waldmann H
    J Immunol; 2004 May; 172(10):6003-10. PubMed ID: 15128783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of GITR in activation response of T lymphocytes.
    Ronchetti S; Nocentini G; Riccardi C; Pandolfi PP
    Blood; 2002 Jul; 100(1):350-2. PubMed ID: 12070049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutting edge: ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis.
    Kohm AP; Williams JS; Miller SD
    J Immunol; 2004 Apr; 172(8):4686-90. PubMed ID: 15067043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
    Burckhart T; Thiel M; Nishikawa H; Wüest T; Müller D; Zippelius A; Ritter G; Old L; Shiku H; Renner C
    J Immunother; 2010; 33(9):925-34. PubMed ID: 20948444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GITR ligation enhances functionality of tumor-infiltrating T cells in hepatocellular carcinoma.
    van Beek AA; Zhou G; Doukas M; Boor PPC; Noordam L; Mancham S; Campos Carrascosa L; van der Heide-Mulder M; Polak WG; Ijzermans JNM; Pan Q; Heirman C; Mahne A; Bucktrout SL; Bruno MJ; Sprengers D; Kwekkeboom J
    Int J Cancer; 2019 Aug; 145(4):1111-1124. PubMed ID: 30719701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.